This improved temporal and spatial resolution makes 18F-PSMA-1007 particularly valuable for precise staging of prostate cancer, especially in the prostatic bed and pelvic nodal regions where conventional PSMA PET tracers face limitations due to urinary excretion artefacts [23,112]. This evidence concerns the gene FOLH1 and prostate carcinoma.